News Detail

Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C

25 May 2011

by:

Read the article

Achillion to Present at Two Upcoming Investor Conferences | LipoScience surpasses six million NMR LipoProfile tests ordered